• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS ONE. 2009; 4(4): e5262.
Published online Apr 16, 2009. doi:  10.1371/journal.pone.0005262
PMCID: PMC2667254

Biomechanical Thresholds Regulate Inflammation through the NF-κB Pathway: Experiments and Modeling

Francois Patrick Rannou, Editor

Abstract

Background

During normal physical activities cartilage experiences dynamic compressive forces that are essential to maintain cartilage integrity. However, at non-physiologic levels these signals can induce inflammation and initiate cartilage destruction. Here, by examining the pro-inflammatory signaling networks, we developed a mathematical model to show the magnitude-dependent regulation of chondrocytic responses by compressive forces.

Methodology/Principal Findings

Chondrocytic cells grown in 3-D scaffolds were subjected to various magnitudes of dynamic compressive strain (DCS), and the regulation of pro-inflammatory gene expression via activation of nuclear factor-kappa B (NF-κB) signaling cascade examined. Experimental evidences provide the existence of a threshold in the magnitude of DCS that regulates the mRNA expression of nitric oxide synthase (NOS2), an inducible pro-inflammatory enzyme. Interestingly, below this threshold, DCS inhibits the interleukin-1β (IL-1β)-induced pro-inflammatory gene expression, with the degree of suppression depending on the magnitude of DCS. This suppression of NOS2 by DCS correlates with the attenuation of the NF-κB signaling pathway as measured by IL-1β-induced phosphorylation of the inhibitor of kappa B (IκB)-α, degradation of IκB-α and IκB-β, and subsequent nuclear translocation of NF-κB p65. A mathematical model developed to understand the complex dynamics of the system predicts two thresholds in the magnitudes of DCS, one for the inhibition of IL-1β-induced expression of NOS2 by DCS at low magnitudes, and second for the DCS-induced expression of NOS2 at higher magnitudes.

Conclusions/Significance

Experimental and computational results indicate that biomechanical signals suppress and induce inflammation at critical thresholds through activation/suppression of the NF-κB signaling pathway. These thresholds arise due to the bistable behavior of the networks originating from the positive feedback loop between NF-κB and its target genes. These findings lay initial groundwork for the identification of the thresholds in physical activities that can differentiate its favorable actions from its unfavorable consequences on joints.

Introduction

Exercise is essential for maintaining the health of cartilage, and is believed to have therapeutic effects on the degenerating cartilages in diseases like osteoarthritis [1], [2]. In addition, continuous passive motion (CPM) has been shown to allay pain and limited mobility due to the disease [3], [4]. Excessive exercise, however, could induce inflammation by itself that promotes damage of cartilage and aggravates the disease [5]. This double-edged sword is an intriguing phenomenon and its understanding has important medical significance. Identification of the threshold in exercise that delineates its favorable from its unfavorable consequences is a key issue being addressed in our laboratory. In this paper, we describe our experimental investigations describing the consequences of mechanical signals applied to chondrocytic cells, and demonstrate the existence of a threshold governing the expression of pro-inflammatory genes. In addition, we present a kinetic model of intracellular networks, and show that the model explains our experiments in ways that could not have been possible in the absence of an integrative mechanistic model.

Exercise generates biomechanical signals that are sensed by chondrocytes which then respond by adjusting their metabolic activities, including expression of genes that regulate inflammation. Chondrocytes perceive these signals, likely through cell surface receptors such as β-integrin and focal adhesion complexes [6], [7]. How these mechanical signals interface with the molecular regulatory pathways of a cell is a crucial question that we and other groups have attempted to answer recently [8], [9], [10]. Indeed, we have shown that the protein complex IκB kinase (IKK) is a key mediator of mechanical signals applied to chondrocytes [8], [10]. This observation establishes the link between the mechanical signals and the pathway of NF-κB activation, a family of dimeric transcription factors that regulate the expression of over two hundred genes, many of which are anti- and pro-inflammatory genes. Detailed biochemical mechanisms of this pathway can be found in an excellent review done by Hoffmann and Ghosh [11].

To apply biomechanical compressive forces to cells in vitro, similar to those experienced by chondrocytes in cartilage, it is necessary to embed cells in a scaffold which can efficiently transmit applied forces. In this study, we have used well-characterized biomechanically active scaffolds in which cultured cells can perceive and distinguish different magnitudes of dynamic compressive forces, and can respond to them accordingly [12], [13]. The differential responses of the cells from experiments were analyzed by linking to the NF-κB signaling pathway. The details of the NF-κB network are discussed in the modeling section of this paper. The network is very complex and mere intuitive reasoning is not sufficient to understand its behavior. This complex network exhibits various feedback loops, both negative and positive. Our mathematical analysis of the kinetic model will show that the positive feedback loops (i.e., the autocrine loops between NF-κB and pro-inflammatory cytokines) in the network are candidates for the mechanistic origins of the thresholds observed experimentally.

Results and Discussion

The well characterized electrospun scaffolds were employed in this study to apply different magnitudes of DCS to the embedded cells. Chondrocytic cells differentiated from mesenchymal cell line, C3H10T1/2, were utilized in all experiments (please see Figure S1 for details). Following 48 hours of cultivation, the cell-scaffold constructs were subjected to various magnitudes of DCS at 1 Hz in the absence or presence of recombinant human IL-1β. The regimens used in this study are shown in Figure 1.

Figure 1
Schematic illustration of experimental regimens.

DCS inhibits or induces pro-inflammatory gene expression in a magnitude-dependent manner

To examine how the magnitude of DCS differentially influences cellular responses, the gene expression of NOS2, one of the early-responsive pro-inflammatory genes was investigated. In the absence of inflammatory stimulus by IL-1β, the applied DCS induced NOS2 gene expression depending on the magnitude of applied forces (solid curve in Fig. 2A). At low magnitudes, the cells did not respond to the applied DCS. However, the NOS2 induction increased proportional to the applied DCS after a certain threshold, resulting in an approximately 300-fold increase at 30% DCS. On the other hand, exogenous IL-1β induced approximately 3000-fold increase in the NOS2 expression (dotted curve in Fig. 2A). Interestingly, the IL-1β-induced gene upregulation was gradually suppressed by the application of DCS up to a threshold, which nearly coincides with the magnitude that initiated NOS2 induction in the absence of the inflammatory cytokine. The gene response was parabolically related to the applied DCS having approximately 10–15% DCS estimated to result in the greatest suppression on IL-1β-induced NOS2 gene expression (dotted curve in Fig. 2A). High magnitudes of DCS were ineffective in suppressing the IL-1β-induced NOS2 gene expression; rather, they intensified the gene expression resulting in approximately 3800-fold increase at 30% DCS. Similar pro-inflammatory gene regulation by DCS was observed in TNF-α (Fig. 2B).

Figure 2
Regulation of pro-inflammatory gene expression by DCS.

DCS differentially regulates protein phosphorylation and degradation in the NF-κB signaling cascade depending on its magnitudes

Based on the differential regulation of NOS2 and TNF-α gene by DCS, the end products controlled by the NF-κB signaling pathway, the phosphorylation and degradation of proteins that regulate the NF-κB activity were investigated (Fig. 3). To confirm the biphasic behavior of DCS in each step of the NF-κB signal cascade, DCSs of 10% and 30% were chosen to represent physiological (anti-inflammatory) and hyper-physiological (pro-inflammatory) levels of stimulation, respectively, based on the inflammatory gene regulation (Fig. 2). IKK activity was estimated by monitoring IκB-α phosphorylation relative to total IκB-α at 15 or 30 minutes (Fig. 3C and 3D). In the absence of the stimulant, the phosphorylation ratio of IκB-α (phospho-IκB-α/total-IκB-α) was proportionally related to the applied DCS at both time points. However, the ratio increased more rapidly at the high magnitude (5-fold increase in 30% from 15 to 30 minutes versus 2-fold increase in 10%). When the cells were subjected to DCS and IL-1β simultaneously, the biomechanical stimulation attenuated the cytokine-induced IκB-α phosphorylation. Interestingly, the suppression of the phosphorylation was observed even in 30% at 15 minutes. However, at 30 minutes, the high magnitude induced higher phosphorylation ratio than IL-1β-treated samples without biomechanical stimulation.

Figure 3
Regulation of IκB-α phosphorylation, and IκB-α and IκB-β degradation by DCS.

Since the phosphorylation of IκB-α directly regulates the degradation of the protein by ubiquitination and proteasomal degradation, the changes in IκB-α were examined (Fig. 3E and 3F). At 15 minutes, IL-1β induced approximately 40% degradation of IκB-α, and this degradation was inhibited by the application of 10% DCS, almost to a similar level as untreated control. High magnitude also seems to suppress the protein degradation agreeing with the phosphorylation result at this early time point. Interestingly, 10% DCS seem to induce IκB-α synthesis resulting in approximately 80% increase in the protein amount (Fig. 3E). Longer treatment time (30 minutes) resulted in larger IκB-α degradation in IL-1β-treated sample, and the degradation was attenuated in the 10% DCS in the presence of the cytokine (Fig. 3F). Correlated to the phosphorylation result at 30 minutes, 30% DCS further intensified the degradation of IκB-α leading to less remaining protein compared to IL-1β treated sample without mechanical stimulation. Furthermore, it was observed that high magnitude of DCS alone could induce IκB-α degradation compared to low magnitude that maintains the protein level similar to untreated control. This may suggest synergistic effect between inflammatory cytokine and hyper-physiological force to accelerate the NF-κB signal cascade. However, further investigations are needed to confirm how and when the high magnitude initiate to influence the inflammatory signaling network since the IL-1β-induced IKK activity was higher than that of high magnitude DCS treated sample in the presence of IL-1β at the earlier time point (Fig. 3C).

In addition to the changes in IκB-α, the degradation of IκB-β was examined, and the results showed similar trend observed in IκB-α degradation (Fig. 3G and 3H). IL-1β-induced degradation of IκB-β was attenuated by the application of 10% DCS while 30% DCS intensified its effect. Moreover, low magnitudes of DCS appeared to upregulate the protein synthesis as opposed to high magnitudes of DCS-induced degradation.

DCS differentially control NF-κB nuclear translocation in a magnitude-dependent manner

NF-κB nuclear translocation, a signaling process downstream of IκB-α and IκB-β degradation, was investigated by immunofluorescence analysis (Fig. 4A). In the absence of IL-1β, 30% DCS applied for 45 minutes induced nuclear translocation of NF-κB as shown in the localized presence of p65 in the nuclei (Fig. 4Aiii), in contrast to its mostly cytoplasmic presence in control (Fig. 4Ai) or 10% DCS (Fig. 4Aii). As expected, the exogenously supplied IL-1β stimulated the NF-κB nuclear translocation evident in Figure 4Aiv. The IL-1β-induced nuclear translocation was inhibited by the applied DCS at 10% (Fig. 4Av) while it was not influenced by 30% DCS (Fig. 4Avi).

Figure 4
Regulation of NF-κB nuclear translocation by DCS.

To examine the applicability of the in vitro observation to in vivo, rat femur explants were subjected to dynamic compression in the presence and absence of IL-1β. In these experiments, the explants were subjected to either physiological levels (3 times of body weight) or hyper-physiological levels (22 times of body weight) of dynamic compression in the absence or presence of IL-1β. The physiological levels of compression resulted in an average pressure of ~400 KPa with a peak pressure of ~600 KPa in the medial condyles, as analyzed by a piezoelectric sensor. For the hyper-physiological levels, an average pressure of ~700 KPa with a peak pressure of ~1800 KPa was recorded. The localization of NF-κB p65 in the sections prepared from the central region of medial condyles was immunofluorescently examined (Fig. 4B). Similar to the in vitro study, the cytoplasmic presence of most of NF-κB was observed in the untreated control (Fig. 4Bi), and nuclear translocation was induced by IL-1β based on the stain-filled nuclei (Fig. 4Bii). Less NF-κB nuclear localization was observed in either physiologically compressed sample in the presence (Fig. 4Biii) or absence (Fig. 4Biv) of IL-1β. However, hyper-physiological high magnitude compression alone induced NF-κB nuclear translocation (Fig. 4Bv).

The mechanistic mathematical model helps understanding the experimental observations

It was shown previously that IKK is the key moleucule regulated by biomechanical signals [8], [10]. Low physiological magnitudes of biomechanical forces prevent phophorylation of TAK1 (TGF-β activating kinase), which in turn inhibits phosphorylation of IKK, resulting in attenuating further downstream NF-κB signaling cascade. Now we show that IKK activity, estimated from the phosphorylation of IκB-α, is regulated by DCS; initially it is suppressed as the magnitude of DCS increases and then increases again with further raising in magnitude (Fig. 3C and 3D). This observation of biphasic IKK activation is incorporated in the model of Figure 5 through the rate coefficient of activation of IKK, that is, k3f(m), where f(m) is a function of DCS magnitude (see Table 1). The factor k3f(m) is referred to as k3eff. A simple choice of the form of the function f(m) is the parabola a(mm0)2, where a is set so that f(0) = 1, and m0 is set so that the observed threshold in the magnitude of DCS is approximated (Fig. 6A) A plot of RNOS2 (NOS2 mRNA) versus k3eff in steady states is given in Figure 6B. These steady states are the long-term levels of RNOS2, and are determined by setting all the differential equations in Table 2 to zero.

Figure 5
Proposed scheme explaining the magnitude-dependent regulation of NF-κB activity by a mathematical model.
Table 1
List of rate expressions and parameter values used in the model (symbols of molecules are given in Figure 5).
Figure 6
Mathematical model predictions of k3eff and RNOS2.
Table 2
Differential equations used for the Model (the rate expressions vi’s are defined in Table 1).

The two lines in Figure 6B indicate that the system exhibits bistability for k3eff between 0 and ~0.024. This phenomenon is characterized by having two stable steady states that coexist for a given set of parameters. The solid curve of Figure 6B explains the origin of the threshold (at m = mth1) observed in the experiment with no initial addition of IL-1β (Fig. 2, solid line), as well as the origin of another threshold mth2 (mth2<mth1), which could not be clearly observed in the experiment. The predicted mth2 is the point where expression of pro-inflammatory gene (NOS2) is completely suppressed in the presence of inflammatory cytokine (Fig. 7A). At k3eff~0.024, corresponding to m = mth1, synthesis of RNOS2 turns on. At k3,eff = 0, corresponding to m = mth2, synthesis of RNOS2 turns off. These two model-predicted thresholds are shown explicitly in Figure 7A. In Figure 7B, the corresponding levels of nuclear NF-κB concentration (Nn) in steady state are shown. The model predicts that the nuclear localization of NF-κB parallels that of the synthesis of RNOS2 which is a target of active NF-κB as experimentally observed [14].

Figure 7
Mathematical model predictions of RNOS2 and NF-κB nuclear concentration.

Note that the computer simulations show an identical threshold (mth1) for the cases with (dotted line) and without IL-1β (solid line) in Figure 7A. However, the model does not predict the accurate levels of RNOS2 observed in the experiment (Figure 2). This discrepancy is expected since the experimental system did not reach an equilibrium state. Furthermore, many simplifying assumptions of the model such as ignoring the hundreds of NF-κB targets that affect NOS2 expression as well as simultaneous activation of other signaling pathways involved in the regulation of NOS2 expression likely affect the equilibrium state of NF-κB [15], [16], [17].

In summary, we present an experimental evidence-based mathematical model that provides insight into the regulation of pro-inflammatory gene by dynamic compressive forces in chondrocytes. The data demonstrates that the magnitude of biomechanical signals perceived by the cells is the critical event that controls the activation or inhibition of pro-inflammatory gene induction, in the presence or absence of an inflammatory stimulus. Furthermore, there exists a threshold in the magnitude of DCS for inducing pro-inflammatory genes even without induction by IL-1β; below this threshold, NOS2 expression is not observed. In the presence of IL-1β, we showed that increasing magnitudes of DCS decreases NOS2 production, but only if the DCS magnitude is less than the aforementioned threshold where NOS2 expression begins to increase again. It is interesting to note that the induction of NOS2 synthesis occurs at the same threshold of DCS magnitude, with or without IL-1β.

We further showed that the NF-κB pathway is involved in the transduction of the mechanical signals generated by DCS. Evidence was presented that the direct interface between mechanical signals and this pathway is IKK, and that the activity of IKK is biphasic (first decreasing and then increasing with increasing DCS magnitude). Using a comprehensive mechanistic model of the NF-κB network and the dependence of IKK activity with the magnitudes of DCS, we were able to explain the existence of the threshold, labeled as mth1 in Figure 7. This threshold arises due to the bistable behavior of the networks originating from the positive feedback loop between NF-κB and its target genes such as IL-1β, TNF-α and NOS2. Interestingly, this model also predicts another threshold shown as mth2 in Figure 7, above which (and below mth1) cytokine-induced NOS2 synthesis is suppressed. This novel model lays the groundwork to explain how biomechanical signals by gentle exercise may inhibit inflammation and restore cartilage, and how at high magnitudes become inflammatory and initiate destruction of the cartilage.

Materials and Methods

Cell culture in 3-D scaffolds

Mesenchymal cell line, C3H10T1/2 cells (ATCC) were expanded in monolayer with a growth medium (DMEM (Gibco), 10% FBS, 10 µg/ml penicillin, 100 U/ml streptomycin, 2 mM L-glutamine). Subsequently, approximately 600,000 cells/scaffold were seeded into well-characterized electrospun poly(ε-caprolactone) scaffolds having 6 mm in diameter and 3 mm in thickness, as described previously [12]. The cells in the scaffolds were cultured for 48 hours in a differentiation medium (Ham's F-12 (Gibco), 10% FBS, 10 ug/ml penicillin, 100 U/ml streptomycin, 2 mM L-glutamine) prior to subjecting to various conditions. Chondrocytic differentiation of the cells in the scaffolds were confirmed by examining the synthesis of glycosaminoglycan using Alcian blue staining and chondrogenic/chondrocytic gene/protein expression using real-time reverse transcription polymerase chain reaction (rt-PCR) and Western blot (Figure S1).

Application of DCS

Following 48 hours of cultivation, the cell-scaffold constructs were subjected to various magnitudes of DCS at 1 Hz in the absence or presence of recombinant human IL-1β (2 ng/ml; Calbiochem) using a custom-made compression device [12]. The regimens used in this study are shown in Figure 1. For NOS2 and TNF-α gene expression analysis, 0%, 7.5%, 15%, 22.5% or 30% of DCS was used. After observing the magnitude-dependent inflammatory gene regulation by biomechanical signals, 0%, 10% (representative regimen for anti-inflammatory magnitude) or 30% (representative regimen for pro-inflammatory magnitude) of DCS was used for protein and immunoflurescence analysis to confirm the immunomodulation through the NF-κB signal transduction.

Analysis of mRNA expression by rt-PCR

After the application of DCS, pro-inflammatory agent or combination of both for 45 minutes, the samples were further incubated for 75 minutes. Total RNA pooled from two samples per condition was subsequently extracted using the RNeasy micro kit as recommended (Qiagen). Total RNA (1 µg) was measured using the Nanodrop spectrophotometer (ND-1000, Nanodrop tech.) and first strand synthesis performed using the Superscript III Reverse Transcriptase Kit (Invitrogen). Custom-designed gene-specific primers were used to perform real time-PCR using the Bio-Rad SYBR Green Master Mix (Bio-Rad) in the iCycler iQ Real-Time PCR System (Bio-Rad). Similarly, total RNAs from monolayer-cultured and scaffold-cultured cells without any treatments were extracted to examine the chondrocytic differentiation of C3H10T1/2 cells, and cDNA synthesized as previously described. Following primers were used: NOS2-sense 5′-CACCAAGCTGAACTTGAGCGA-3′, NOS2-anti-sense 5′-GCCCCATAGGAAAAGACTGCA-3′; TNF-α-sense 5′- AGAGGCACTCCCCCAAAAGAT-3′, TNF-α-anti-sense 5′- TGCCACAAGCAGGAATGAGA-3′; RPS18-sense 5′-GGAAAATAGCCTTCGCCATCACT-3′, RPS18-anti-sense 5′-GCCAGTGGTCTTGGTGTGCTGAC-3′; WNT5A-sense 5′-GGCATCAAGGAATGCCAGTA-3′, WNT5A-anti-sense 5′-GTACGTGAAGGCCGTCTCTC-3′; SOX9-sense 5′-AACGGCTCCACTCAAGAACAAG-3′, SOX9-anti-sense 5′-TCCGTTCTTCACCGACTTCCTC-3′; ACAN-sense 5′-ACTGTCAAAGCACCATGCCTT-3′, ACAN-anti-sense 5′-CCATTCAGTCTGTTTTCTTGCC; COL2A1-sense 5′-AAACTGGTGGAGCAGCAAGAG-3′, COL2A1-anti-sense 5′-ATCTGGACGTTAGCGGTGTTG-3′. The thermocycling protocol was: 95°C for 3 min, 40 cycles of denaturation at 95°C for 30 s, annealing at 60°C for 30 s, and extension at 72°C for 30 s. Collected data were analyzed by the comparative threshold cycle (CT) method using RPS18 expression as an endogenous normalization control.

Protein phosphorylation and degradation

Activation and degradation of proteins in the NF-κB signaling pathway were analyzed by Western blot after the application of DCS in the absence or presence of IL-1β for 15 or 30 minutes as indicated in Figure 1. Total cell extracts (40 µg/lane) were separated by SDS-10% PAGE and then electrophoretically transferred onto nitrocellulose membrane (Bio-Rad). The blots were subsequently probed with anti-phospho-ser32/36-IκB-α (Cell Signaling), anti-IκB-α and anti-IκB-β (Santa Cruz Biotechnology). The bound primary antibodies were detected by either IR-Dye 680 or 800 conjugated secondary antibodies (LI-COR Biosciences). To normalize protein loading, the membranes were probed with anti-β-actin (Sigma-Aldrich) and detected by IR-Dye labeled secondary antibodies. The bands were densitometrically analyzed by LiCor Odyssey imaging system (LiCor).

Immunofluorescence

Following the treatments of the cell-scaffold constructs as indicated in Figure 1, the samples were fixed with 2% paraformaldehyde. The fixed constructs were horizontally cut in the middle followed by cell permeabilization with 0.2% Triton-X for 30 minutes. Cells were then stained with anti-p65 primary antibody (Santa Cruz Biotechnology) and CY3-conjugated secondary antibody (Jackson ImmunoResearch Laboratories). To reveal the morphology of the cells, F-actin was subsequently stained with fluorescein isothiocyanate (FITC) labeled phalloidin (Sigma-Aldrich). The stained samples were observed under an epifluorescence microscope (Axioplan2; Carl Zeiss).

Compression of femur explants and immunohistochemical analysis

The femur explants were obtained from 10–12-week-old female Sprague-Dawley rats (Harlan) and kept in ice-cold PBS. Prior to experiments, the explants were equilibrated to 37°C in serum-free culture medium (Ham's F-12, 10 µg/ml penicillin, 100 U/ml streptomycin). A computer controlled load frame (Model 1000R12; TestResources) equipped with an electronically calibrated 50 lb load cell (Model SM-50; TestResources) was used. Using load control, condyle-side of rat femur held by a custom-made fixture was compressed against a ½ inch-thick ultra-soft polyurethane sheet in various conditions including dynamic compression of approximately 3 times of body weight (2 lbs) at 0.5 Hz for 30 minutes, or approximately 22 times of body weight (15 lbs) at 0.1 Hz for 10 times followed by 30 minutes of incubation, in the absence or presence of IL-1β (5 ng/ml) in serum-free culture medium. A computerized contact area and pressure measurement system, K-Scan 4000 (Tekscan) was placed between the rat femur and the polyurethane sheet to assess differential peak pressure with respect to contact area. The peak pressure per area was calculated by the captured image analysis. Each condition was performed three times with femurs obtained from different animals.

Following the application of dynamic compression and pressure measurements, the samples were fixed in 10% formalin solution. The fixed samples were decalcified using Cal-EX (Fisher Scientific), and embedded in paraffin for sectioning. The sections of medial condyles were re-hydrated using xylene and ethanol-water series, then subsequently stained with NF-κB p65 primary antibody (Santa Cruz Biotechnology) and CY3-conjugaed secondary antibody (Jackson ImmunoResearch Laboratories). The stained sections were observed under an epifluorescence microscope.

Statistical Analysis

At least two independent experiments were performed and the most representative data has been presented. For phenotypic characterization of the cells, T-test was used to determine statistical significance (*; p≤0.05, **; p≤0.01) in comparisons made between the monolayer-cultured and the 3-D scaffold-cultured cells.

Model of the NF-κB network with mechanical signaling

The mechanistic steps comprising the model NF-κB network are shown in Figure 5. Many of the steps are similar to a model of the Hoffmann group [18]; the essential additions are the steps for the production of cytokine (Pc and Po) and the effect of mechanical signal (represented by a function f(m) of the mechanical load m) on the activation of IKK. Description of the individual steps and their rate expressions, and the parameter values used are listed in Table 1. The differential equations that describe the dynamics of the system are given in Table 2. An essential feature of the model is the function f(m) which incorporates experimental observations on how the magnitude of mechanical signals affect the activity of the enzyme IKK. The form of the function f(m) used in Table 1 encodes our observation that, as m increases, inflammatory products is initially inhibited in the presence of exogenous cytokine (IL-1β) but increases after reaching a certain threshold value of m. It is not yet known exactly how mechanical signaling interfaces with the molecular network shown in Figure 5. The set of ordinary differential equations in Table 2 is numerically solved using the software BerkeleyMadonna (www.berkeleymadonna.com).

Supporting Information

Figure S1

Chondrogenesis of mesenchymal cells in 3-D culture. C3H10T1/2 cells were cultured in electrospun scaffolds for 48 hours and the proteoglycan synthesis was assessed by Alcian blue staining (A), gene expression by real time RT-PCR (B), and protein expression by Western blot (C). (A) The cell-scaffold constructs showed the presence of proteoglycan synthesis on the top surface, and in cross sections through 1/4, 1/2 and 3/4 height of the scaffolds confirming significant deposition of extracellular matrix. (B) chondrogenic (WNT5A and SOX9) and chondrocytic (ACAN and COL2) gene expression in cells grown in the scaffolds (black bars) compared to those grown in the tissue culture dishes (gray bars) confirming the chondrocytic differentiation of the cells by 3-D culture (n = 6, *; p<0.05, **; p<0.01). (C) Aggrecan, collagen type II and type I protein expression for the cells grown in the tissue culture dishes (left lane, monolayer) and in the scaffolds (right lane, scaffold) (representative gels out of three separate experiments are shown); scaffold-cultured cells expressed aggrecan and collagen type II proteins while no expression of those was observed in the tissue culture dish grown cells. In addition, collagen type I protein expression was substantially suppressed in the scaffold-cultured cells.

(4.51 MB TIF)

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by the National institute of Health grants AR048781 and AT000646. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Fransen M, McConnell S, Bell M. Therapeutic exercise for people with osteoarthritis of the hip or knee. A systematic review. Journal of Rheumatology. 2002;29:1737–1745. [PubMed]
2. Hernandez-Molina G, Reichenbach S, Zhang B, Lavalley M, Felson DT. Effect of therapeutic exercise for hip osteoarthritis pain: results of a meta-analysis. Arthritis Rheum. 2008;59:1221–1228. [PMC free article] [PubMed]
3. Ferretti M, Srinivasan A, Deschner J, Gassner R, Baliko F, et al. Anti-inflammatory effects of continuous passive motion on meniscal fibrocartilage. J Orthop Res. 2005;23:1165–1171. [PubMed]
4. Simkin PA, de Lateur BJ, Alquist AD, Questad KA, Beardsley RM, et al. Continuous passive motion for osteoarthritis of the hip: a pilot study. J Rheumatol. 1999;26:1987–1991. [PubMed]
5. Buckwalter JA. Sports, joint injury, and posttraumatic osteoarthritis. Journal of Orthopaedic & Sports Physical Therapy. 2003;33:578–588. [PubMed]
6. Goldmann WH. Mechanical aspects of cell shape regulation and signaling. Cell Biol Int. 2002;26:313–317. [PubMed]
7. Ingber DE. Tensegrity: the architectural basis of cellular mechanotransduction. Annu Rev Physiol. 1997;59:575–599. [PubMed]
8. Dossumbekova A, Anghelina M, Madhavan S, He L, Quan N, et al. Biomechanical signals inhibit IKK activity to attenuate NF-kappaB transcription activity in inflamed chondrocytes. Arthritis Rheum. 2007;56:3284–3296. [PubMed]
9. Gabay O, Gosset M, Levy A, Salvat C, Sanchez C, et al. Stress-induced signaling pathways in hyalin chondrocytes: inhibition by Avocado-Soybean Unsaponifiables (ASU). Osteoarthritis Cartilage. 2008;16:373–384. [PubMed]
10. Madhavan S, Anghelina M, Sjostrom D, Dossumbekova A, Guttridge DC, et al. Biomechanical signals suppress TAK1 activation to inhibit NF-kappaB transcriptional activation in fibrochondrocytes. J Immunol. 2007;179:6246–6254. [PubMed]
11. Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene. 2006;25:6706–6716. [PubMed]
12. Nam J, Rath B, Knobloch TJ, Lannutti JJ, Agarwal S. Novel Electrospun Scaffolds for the Molecular Analysis of Chondrocytes Under Dynamic Compression. Tissue Eng Part A. 2009;15:513–523. [PMC free article] [PubMed]
13. Rath B, Nam J, Knobloch TJ, Lannutti JJ, Agarwal S. Compressive forces induce osteogenic gene expression in calvarial osteoblasts. J Biomech. 2008;41:1095–1103. [PMC free article] [PubMed]
14. Agarwal S, Deschner J, Long P, Verma A, Hofman C, et al. Role of NF-kappaB transcription factors in antiinflammatory and proinflammatory actions of mechanical signals. Arthritis Rheum. 2004;50:3541–3548. [PubMed]
15. Darnell JE, Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415–1421. [PubMed]
16. Delarue FL, Taylor BS, Sebti SM. Ras and RhoA suppress whereas RhoB enhances cytokine-induced transcription of nitric oxide synthase-2 in human normal liver AKN-1 cells and lung cancer A-549 cells. Oncogene. 2001;20:6531–6537. [PubMed]
17. Kunz D, Muhl H, Walker G, Pfeilschifter J. Two distinct signaling pathways trigger the expression of inducible nitric oxide synthase in rat renal mesangial cells. Proc Natl Acad Sci U S A. 1994;91:5387–5391. [PMC free article] [PubMed]
18. Werner SL, Barken D, Hoffmann A. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science. 2005;309:1857–1861. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...